Purpose: Contouring inconsistencies are known but understudied in clinical radiation therapy trials. We applied auto-contouring to the Radiation Therapy Oncology Group (RTOG) 0617 dose escalation trial data. We hypothesized that the trial heart doses were higher than reported due to inconsistent and insufficient heart segmentation. We tested our hypothesis by comparing doses between deep-learning (DL) segmented hearts and trial hearts.
Methods And Materials: The RTOG 0617 data were downloaded from The Cancer Imaging Archive; the 442 patients with trial hearts and dose distributions were included. All hearts were resegmented using our DL pipeline and quality assured to meet the requirements for clinical implementation. Dose (V5%, V30%, and mean heart dose) was compared between the 2 sets of hearts (Wilcoxon signed-rank test). Each dose metric was associated with overall survival (Cox proportional hazards). Lastly, 18 volume similarity metrics were assessed for the hearts and correlated with |Dose - Dose| (linear regression; significance: P ≤ .0028; corrected for 18 tests).
Results: Dose metrics were significantly higher for DL hearts compared with trial hearts (eg, mean heart dose: 15 Gy vs 12 Gy; P = 5.8E-16). All 3 DL heart dose metrics were stronger overall survival predictors than those of the trial hearts (median, P = 2.8E-5 vs 2.0E-4). Thirteen similarity metrics explained |Dose - Dose|; the axial distance between the 2 centers of mass was the strongest predictor (CENT; median, R = 0.47; P = 6.1E-62). CENT agreed with the qualitatively identified inconsistencies in the superior direction. The trial's qualitative heart contouring score was not correlated with |Dose - Dose| (median, R = 0.01; P = .02) or with any of the similarity metrics (median, Rs = 0.13 [range, -0.22 to 0.31]).
Conclusions: Using a coherent heart definition, as enabled through our open-source DL algorithm, the trial heart doses in RTOG 0617 were found to be significantly higher than previously reported, which may have led to an even more rapid mortality accumulation. Auto-segmentation is likely to reduce contouring and dose inconsistencies and increase the quality of clinical RT trials.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729313 | PMC |
| http://dx.doi.org/10.1016/j.ijrobp.2020.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dosimetric Planning Comparison for Left Ventricle Avoidance in Non-small Cell Lung Cancer Radiotherapy.
Cureus
December 2024
Physics and Engineering, London Regional Cancer Program, London, CAN.
Introduction: Radiation may unintentionally injure myocardial tissue, potentially leading to radiation-induced cardiac disease (RICD), with the net benefit of non-small cell lung cancer (NSCLC) radiotherapy (RT) due to the proximity of the lung and heart. RTOG-0617 showed a greater reduction in overall survival (OS) comparing higher doses to standard radiation doses in NSCLC RT. VHeart has been reported as an OS predictor in the first- and fifth-year follow-ups.
View Article and Find Full Text PDFThe influence of cardiac substructure dose on survival in a large lung cancer stereotactic radiotherapy cohort using a robust personalized contour analysis.
Phys Imaging Radiat Oncol
October 2024
Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
Background/purpose: Radiation-induced cardiac toxicity in lung cancer patients has received increased attention since RTOG 0617. However, large cohort studies with accurate cardiac substructure (CS) contours are lacking, limiting our understanding of the potential influence of individual CSs. Here, we analyse the correlation between CS dose and overall survival (OS) while accounting for deep learning (DL) contouring uncertainty, uncertainty and different modelling approaches.
View Article and Find Full Text PDFDosimetric comparison between laterality-specific and general knowledge-based planning models for nonsmall cell lung cancer.
Med Dosim
November 2024
Department of Radiation Oncology, Emory University, Atlanta, GA, USA.
To investigate the dosimetric impact of laterality-specific RapidPlan models for nonsmall cell lung cancer. Three RapidPlan models were developed and validated for Right, Left, and General conventional lung radiotherapy. Each model was trained using 50 plans.
View Article and Find Full Text PDFApplication of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial.
BJR Open
January 2024
Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States.
Objectives: To apply CT-based foundational artificial intelligence (AI) and radiomics models for predicting overall survival (OS) for patients with locally advanced non-small cell lung cancer (NSCLC).
Methods: Data for 449 patients retrospectively treated on the NRG Oncology/Radiation Therapy Oncology Group (RTOG) 0617 clinical trial were analyzed. Foundational AI, radiomics, and clinical features were evaluated using univariate cox regression and correlational analyses to determine independent predictors of survival.
Importance: The optimal radiotherapy technique for unresectable locally advanced non-small cell lung cancer (NSCLC) is controversial, so evaluating long-term prospective outcomes of intensity-modulated radiotherapy (IMRT) is important.
Objective: To compare long-term prospective outcomes of patients receiving IMRT and 3-dimensional conformal radiotherapy (3D-CRT) with concurrent carboplatin/paclitaxel for locally advanced NSCLC.
Design, Setting, And Participants: A secondary analysis of a prospective phase 3 randomized clinical trial NRG Oncology-RTOG 0617 assessed 483 patients receiving chemoradiotherapy (3D-CRT vs IMRT) for locally advanced NSCLC based on stratification.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!